RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

RAPT Therapeutics (Nasdaq: RAPT) will present a company overview at the 44th Annual J.P.

Rhea-AI Summary

RAPT Therapeutics (Nasdaq: RAPT) will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference. Brian Wong, M.D., Ph.D., President and CEO, is scheduled to present on Wednesday, January 14, 2026 at 2:15 p.m. PT. Investors can access a live webcast and an archived recording via the company’s investor website.

This presentation is a corporate overview at a major industry conference and does not include new financial guidance or clinical readouts in the announcement.

Argus Jan 8 session

-3.76% close to close Open Argus

Details

News Market Reaction – RAPT

In the Jan 8 session, RAPT declined 3.76%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights RAPT’s participation in a major healthcare investor conference, offerin...

Analysis

This announcement highlights RAPT’s participation in a major healthcare investor conference, offering management a platform to reiterate strategy and recent progress. It follows key milestones such as the prestIgE Phase 2b trial initiation and a late-2025 equity raise. With the stock trading at $30.83, above its 200-day MA of $17.34 yet below the $42.3918 52-week high, investors may focus on any new clinical, financial, or portfolio insights shared during the January 14, 2026 presentation.

Key Figures

Conference edition: 44th Presentation date: January 14, 2026 Presentation time: 2:15 p.m. Pacific Time

Conference edition

44th

44th Annual J.P. Morgan Healthcare Conference

Presentation date

January 14, 2026

Scheduled company overview presentation

Presentation time

2:15 p.m. Pacific Time

Scheduled conference presentation slot

Historical Context

5 past events · Latest: Nov 06

5 events

1. Nov 06

   Earnings and update

   24h Move

   +2.7%

   Q3 2025 results plus IND clearance and cash runway extension to mid-2028.

2. Nov 04

   Investor conferences

   24h Move

   -2.9%

   Announcement of participation in three November 2025 investor conferences.

3. Oct 27

   Clinical trial start

   24h Move

   +1.9%

   Initiation of prestIgE Phase 2b ozureprubart trial in food allergy.

4. Oct 21

   Public offering priced

   24h Move

   -0.4%

   Pricing of public offering of 8,333,334 shares at $30.00 per share.

5. Oct 21

   Offering announced

   24h Move

   -0.4%

   Announcement of proposed underwritten public offering of common stock.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44^thAnnual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific Time.

To access the live webcast or subsequent archived recording of the presentation, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

About RAPT Therapeutics, Inc.
RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.

RAPT Investor Contact:
Sylvia Wheeler
swheeler@wheelhouselsa.com

RAPT Media Contact:
Aljanae Reynolds
areynolds@wheelhouselsa.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will RAPT (NASDAQ: RAPT) present at the J.P. Morgan Healthcare Conference in 2026?

RAPT will present on January 14, 2026 at 2:15 p.m. Pacific Time.

Who will present for RAPT Therapeutics (RAPT) at the JP Morgan 2026 conference?

Brian Wong, M.D., Ph.D., President and CEO will deliver the company overview.

How can investors watch the RAPT (RAPT) presentation at the 44th J.P. Morgan Healthcare Conference?

Investors can access a live webcast and archived recording on RAPT’s investor events and presentations webpage.

Will RAPT (NASDAQ: RAPT) release new financial guidance or clinical data during the January 14, 2026 presentation?

The announcement describes a company overview presentation and does not state any new financial guidance or clinical readouts.

Where can I find the archived recording of RAPT Therapeutics (RAPT) presentation after January 14, 2026?

The archived recording will be available on the company’s investor website under events and presentations.